Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: September 09 2019 5:10 pm
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Notice of the National Heart, Lung, and Blood Institute (NHLBI) Participation in RFA-MD-15-005 "NIH Big Data to Knowledge (BD2K) Enhancing Divers NOT-HL-15-250 NHLBI Jan 16 2015 N/A Notice the National Heart, Lung, Blood Institute NHLBI) Participation RFA-MD-15-005 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-HL-15-250 Key Dates Release Date: January 16, 2015 Related Announcements RFA-MD-15-005 Issued National Heart, Lung, Blood Institute NHLBI) Purpose purpose this Notice to inform potential applicants the National Heart, Lung, Blood Institute NHLBI) participating, effective immediately, RFA-MD-15-005, quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections RFA-MD-15-005 been updated reflect NHLBI's participation this funding opportunity announcement. Part 1.  Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Cancer Institute NCI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Center Complementary Alternative Medicine NCCAM) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Strategic Coordination Common Fund) National Heart, Lung, Blood Institute NHLBI) Catalog Federal Domestic Assistance CFDA) Numbers 93.307; nbsp;93.350;  93.213; 93.398; 93.399; 93.172; 93.866; 93.273; 93.855; 93.856; 93.846; 93.286; 93.865; 93.279; 93.173; 93.121; 93.847; 93.859; 93.242; 93.853; 93.361; 93.879; 93.351; 93.310; 93.394; 93.395; 93.396; 93.397; 93.399; 93.837; 93.838; 93.839; 93.233 Inquiries Please direct inquiries to: Weiniu Gan, Ph.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0202 Email: ganw2@mail.nih.gov nbsp; data science, big data
Notice of Technical Assistance Webinar for RFA-LM-16-001 "NLM Institutional Training Grants for Research Training in Biomedical Informatics and NOT-LM-16-003 NLM Mar 03 2016 N/A Notice Technical Assistance Webinar RFA-LM-16-001 NLM Institutional Training Grants Research Training Biomedical Informatics Data Science T15)" Notice Number: NOT-LM-16-003 Key Dates Release Date:   March 3, 2016 Related Announcements RFA-LM-16-001     Issued National Library Medicine NLM) Purpose Notice to inform scientific community a technical assistance webinar RFA-LM-16-001 quot;NLM Institutional Training Grants Research Training Biomedical Informatics Data Science T15)". NLM hold pre-application webinar Wednesday, March 23, 2016 2:00 pm EDT provide opportunity NLM staff explain goals RFA-LM-16-001, quot;NLM Institutional Training Grants Research Training Biomedical Informatics Data Science", to answer questions interested parties. prospective applicants invited participate. session provide brief overview the funding announcement, followed responses questions received advance. Topics include program goals, budget factors, review criteria timing awards.  Prospective applicants encouraged submit questions the FOA nlmepinfo@mail.nih.gov advance the event. questions, please enter quot;Question NLM Training" the subject line your message.  full funding opportunity announcement available http://grants.nih.gov/grants/guide/rfa-files/RFA-LM-16-001.html .  Details a web link join pre-application webinar be posted the NLM Extramural programs web site http://www.nlm.nih.gov/ep close business March 18, 2016. Following webinar, link the questions answers archive be posted http://www.nlm.nih.gov/ep will available until April 19, 2016. Potential applicants miss webinar encouraged use archive a source answers their questions. Any additional questions addressed the archive be directed the contact listed below. Participation this webinar, although encouraged, optional is required the submission an application RFA-LM-16-001. Inquiries Please direct inquiries to: Dr. Valerie Florance National Library Medicine NLM) Telephone: 301-496-4621 Email: florancev@mail.nih.gov data science, informatics
Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adopt NOT-OD-19-127 NIH Jul 30 2019 N/A Notice Special Interest: Small Business Innovation Research SBIR) Small Business Technology Transfer STTR) Applications Directed the Adoption the Fast Healthcare Interoperability Resources FHIR®) Standard Notice Number: NOT-OD-19-127 Key Dates Release Date: July 30, 2019 First Available Due Date: September 5, 2019 Expiration Date:April 7, 2020 Related Announcements PA-19-270 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) PA-19-271 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Required) PA-19-272 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) PA-19-273 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Required) PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) Issued OFFICE THE DIRECTOR, NATIONAL INSTITUTES HEALTH OD) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Purpose purpose this Notice to inform SBIR STTR applicants awardees areas special interest related the of Fast Healthcare Interoperability Resources FHIR®) standard the development health information technology health IT) products services. Health can improve health care quality outcomes enabling health care providers effectively share information apply evidence support care decisions. NIH seeking innovative health solutions, implementing FHIR standard, enable effective patient-centered care coordination, population health management, data science research support. FHIR a standardized of transmitting health data one health information system another through API. API a specified set protocols data standards establish ground rules which information system directly communicates another. Software developers seamlessly connect program another computer through FHIR API transmit electronic health data. FHIR enables exchange many different health data types such clinical information, demographics, billing claims data. special relevance, complementary specification, Substitutable Medical Applications, Reusable Technologies SMART) FHIR, enables third party applications apps) access data electronic health record EHR) systems approved purposes, including research. FHIR also specifies of specific coding systems required interoperability health data. Several Federal health agencies promoting use FHIR EHR systems. 21st Century Cures Act requires a health information technology developer entity allow health information…to accessed, exchanged, used without special effort through use application programming interfaces APIs)… including providing access all data elements a patient's electronic health record.”[1] To implement provision, Department Health Human Services, Office the National Coordinator Health Information Technology ONC) proposed new rule support seamless secure access, exchange, use electronic health information.[2] Specifically, proposed rule calls the health care industry adopt standardized APIs using FHIR standard share patient data. NIH issuing Notice highlight interest receiving grant administrative supplement applications focused implementation the FHIR standard health applications including, not limited to, following area(s): Integration patient- population-level data EHR systems Access and management electronic health information Development clinical decision support systems Exchange EHR data health documentation Enhancement privacy security electronic health information Inclusion common data elements CDEs) clinical terminologies improve interoperability EHR data research clinical care Support a common structure sharing clinical research data Integration EHR patient-originated data clinical research data Design monitoring clinical trial protocols Enhancement patient recruitment, enrollment, consent clinical trials Application Submission Information Submit applications this initiative using of following funding opportunity announcements FOAs) any reissues these announcement through expiration date this notice. Activity Code FOA First Available Due Date R43/R44 PA-19-272: PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) September 5, 2019 R41/R42 PA-19-270: PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-273: PHS 2019-02 Omnibus Solicitation the NIH Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Required) September 5, 2019 R41/R42 PA-19-271: PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Required) September 5, 2019 R41/R42 R43/R44 PA-18-591: Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) September 5, 2019 Competing grant applications submitted response PA-19-270, PA-19-271, PA-19-272, PA-19-273: Applications be submitted due dates or after September 5, 2019 subsequent receipt dates through April 7, 2020. instructions the SF424 R&R) Application Guide and funding opportunity announcement used submission must followed, the following additions: funding consideration, applicants must include NOT-OD-19-127” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applications nonresponsive the terms this notice the FOA used submission be withdrawn Non-competing administrative supplement applications submitted response PA-18-591: Applications be submitted September 5, 2019 through expiration date this notice, April 7, 2020. instructions the SF424 R&R) Application Guide and PA-18-591 must followed, the following additions: Applications due 5:00 PM local time applicant organization. process Streamlined Submissions using eRA Commons cannot used this initiative. funding consideration, applicants must include NOT-OD-19-127” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response this FOA order facilitate efficient processing the request. 1] Section 4002(D)(iv) the 21st Century Cures Act (P.L. 114 – 255) 2] https://www.federalregister.gov/documents/2019/03/04/2019-02224/21st-cen... Inquiries Please direct inquiries to: Scientific/Research, Peer Review, Financial/Grants Management contacts Section VII the listed funding opportunity announcements. data science, data integration, common data, data standards
Notice of Special Interest for Small Business Research in Genomics NOT-GM-19-041 NIGMS May 15 2019 N/A Notice Special Interest Small Business Research Genomics Notice Number: NOT-GM-19-041 Key Dates Release Date: 15, 2019 Related Announcements PAR-18-779 - Novel Genomic Technology Development R43/R44 Clinical Trial Allowed) PAR-19-061 -Computational Genomics Data Science Opportunities Small Business R43/R44 Clinical Trial Allowed) PA-19-043 - Novel Approaches Relating Genetic Variation Function Disease R43/R44 Clinical Trial Allowed) PA-19-034 - Commercializing Understudied Proteins the Illuminating Druggable Genome Project IDG) R43/R44 Clinical Trial Allowed) Issued National Institute General Medical Sciences NIGMS) Purpose National Institute General Medical Sciences NIGMS) issuing Notice highlight interest receiving Small Business Innovation Research SBIR) Small Business Technology Transfer STTR) grant applications focused the following areas: Improvement methodology technology) genetic analysis e.g., gene expression, probes), including procedures the separation analysis nucleic acids proteins these relate genetic problems. Improvement procedures statistical, computational, laboratory) the analysis gene flow gene dynamics human populations. Development improved vectors gene transfer. Development tools technologies detect monitor complex human phenotypes traits. Improvement procedures statistical, computational, laboratory) the high- medium-throughput analysis gene expression patterns regulatory networks. Development improvement methods high throughput detection epigenomic changes. Development improved novel methodology structure/function analysis very large macromolecular complexes involved transmission expression genetic material. Development new innovative tools methods bioinformatics computational biology. Development tools technologies a biomedical data science ecosystem biomedical research. Technologies findability, interconnectivity, interoperability biomedical data sets resources, integration existing data management tools development new ones, universalization innovative algorithms tools. Development ontologies modules useful combining mining databases containing genotype phenotype information order discover correlations drug effects, either therapeutic adverse. Development methods strategies characterize function kinases, ion channels G-protein coupled receptors development cell signaling molecules signaling intermediates, particularly those related G-protein coupled receptors ultimately leading the commercialization understudied proteins identified the Illuminating Druggable Genome" project. Application Submission Information Notice applies application due dates the dates indicated below subsequent due dates through expiration date the FOA. following funding opportunity announcements FOAs) must used submissions this initiative. Although NIGMS not listed a Participating Organization the FOAs listed below, applications this initiative be accepted. Activity Code FOA First Available Due Date R43/R44 PAR-18-779, Novel Genomic Technology Development R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PAR-19-061, Computational Genomics Data Science Opportunities Small Business R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-043, Novel Approaches Relating Genetic Variation Function Disease R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-034, Commercializing Understudied Proteins the Illuminating Druggable Genome Project IDG) R43/R44 Clinical Trial Allowed) September 5, 2019 instructions the SF424 R&R) Application Guide and listed funding opportunity announcements must followed, the following additions: funding consideration, applicants must include NOT-GM-19-041" (without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applications non-responsive terms this Notice be withdrawn. Inquiries Please direct inquiries to: Scientific/Research Contact: Dmitriy Krepkiy, Ph.D. National Institute General Medical Sciences Email: dmitriy.krepkiy@nih.gov Financial Grants Management Contact: Brian Iglesias National Institute General Medical Sciences Email: iglesiab@mail.nih.gov data science, computational, bioinformatics, computational biology
Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (Parent R01 Clinical Trial Not Allowed) NOT-HL-19-712 NHLBI Aug 15 2019 N/A Notice Special Interest NOSI): IDEA2Health: Innovative Data Evaluation Analysis Health Parent R01 Clinical Trial Allowed) Notice Number: NOT-HL-19-712 Key Dates Release Date: August 15, 2019 First Available Due Date: October 5, 2019 Expiration Date: January 8, 2022 Related Announcements NOT-HL-19-678: Bold New Bioengineering Research Heart, Lung, Blood, Sleep Disorders Diseases NOT-HL-19-676: Integrative Omics Analysis NHLBI TOPMed Data PA-19-056: NIH Research Project Grant Parent R01 Clinical Trial Allowed) Issued National Heart, Lung, Blood Institute NHLBI) Purpose purpose this Notice Special Interest NOSI) to inform applicants the National Heart, Lung, Blood Institute NHLBI) an area special interest the development utilization data science methodologies gaining new insights improve health heart, lung, blood sleep HLBS) domains  . Background Vast quantities structured unstructured data, sources such high-dimensional medical imaging, satellite imagery spatial data, physiological signals, smart electronic mobile devices, currently being generated biomedical research use. However, numerous challenges exist the phases the analytics life cycle – data wrangling, model building, assessment deployment. specific examples issues challenges are: extracting value raw complex data; handling multicollinearity, missing values, confounding bias; auto-detecting outliers noise; improving misclassification precise analysis; optimizing predictability an independent data set. rise machine learning ML) artificial intelligence AI) techniques enabled advent relevant solutions impacting health help train” computer systems auto-tuning finding insights faster more accurately. address new challenges, NIH articulated specific priorities encourages rapid open sharing scientific efforts development dissemination innovative data analytics approaches Goal 3, NIH Strategic Plan Data Science). NHLBI also recognized need developing innovative data science approaches enhance integration, analysis, interpretation data multiple sources gain insights the biological, social, environmental, behavioral determinants associated HLBS health disease Objective 7, Leverage emerging opportunities data science open new frontiers, NHLBI Strategic Vision, NIH Publication 16-HL-6150). order stimulate novel approaches this field, NHLBI seeking applications will further novel broader of data science methods, to include team-based approaches these research efforts. is hoped research outputs i.e., data, metadata, tools, algorithms, program code, tutorials, findings, etc.) potentially lead impactful analytic decision-making both the individual public health levels. Potential new knowledge be gained include: improved understanding how environmental factors interact individuals impact onset clinical health/disease; automation identifying, classifying, subtyping a disease condition; optimization algorithms personalized treatment, precision medicine precision prevention HLBS diseases conditions; generation novel research hypotheses. Research Objectives specific research objectives this NOSI to: 1) stimulate advancement employment novel data science methods gaining novel insights; 2) enable innovative engineering solutions better faster data analytics; 3) communicate research outputs through open-science platforms. innovative methodologies data science focus on, example, artificial intelligence, machine learning, deep-learning, combinations these techniques. scope scientific questions must of relevance the mission NHLBI aligned within the NHLBI’s Strategic Vision, NIH Publication 16-HL-6150. Multiple principle investigators key personnel complementary disciplines example, biostatistics/statistics, mathematics; computer science, engineering; biology, medicine, environmental science, social science, etc.) encouraged jointly participate. Research plans actively adhere open-science FAIR Findable, Accessible, Interoperable, Reusable) principles be greatest interest NHLBI. Research outputs include need be limited open-source, reusable, high-quality metadata; smart tools; algorithms; documentation; supplemental materials; presentations conferences publications containing guidelines examples, tutorials, source code. Sharing resources effective communication outputs appropriate interest broader communities essential elements applications. topics related TOPMed computational systems biology analysis trans-omics data, please check NOT-HL-19-676. Application Submission Information notice applies due dates or after October 5, 2019, subsequent receipt dates through January 8, 2022. Applications response this Notice must submitted through NIH Parent Announcement PA-19-056: NIH Research Project Grant Parent R01 Clinical Trial Allowed). All instructions the SF424 R&R) Application Guide and PA-19-056 must followed, the following additions: IMPORTANT: funding consideration, applicants must include NOT-HL-19-712 in Agency Routing Identifier field Box 4b) the SF424 R&R) Form. Applications without information Box 4b not considered this initiative. Applications nonresponsive the terms this Notice be be considered this initiative. Investigators planning submit application response this NOSI strongly encouraged contact discuss proposed research/aims an NHLBI program officer listed this NOSI well advance the grant receipt date. Inquiries Please direct inquiries the contacts Section VII the listed funding opportunity announcements the following additions/substitutions: Scientific/Research Contact(s) Lucy L. Hsu National Heart, Lung, Blood Institute NHLBI) Telephone: 301-402-3276 Email: lucy.hsu@nih.gov     data science, computational, artificial intelligence, machine learning, deep learning, statistics
Notice of Special Interest (NOSI): Computational and Statistical Methods to Enhance Discovery from Health Data NOT-LM-19-003 NLM Mar 19 2019 N/A Notice Special Interest NOSI): Computational Statistical Methods Enhance Discovery Health Data Notice Number: NOT-LM-19-003 Key Dates Release Date: March 19, 2019 Related Announcements PAR-18-896 Issued National Library Medicine NLM) Purpose National Library Medicine issuing Notice highlight interest receiving grant applications through NLM Research Grants Biomedical Informatics Data Science R01 Clinical Trial Optional) PAR 18-896), focused research reduce mitigate gaps errors health data sets. Background Recent successes the of data-centric artificial intelligence AI) methods such deep learning stimulating interest the promise harnessing large complex digital health data sets advance goals precision medicine. Applying AI methods large health data sets promises provide new powers discovery, diagnosis, prediction, decision support aimed improving health outcomes reducing healthcare costs. Numerous public datasets human non-human data available, a rich array specialized tools platforms be used studies applications. However, recent work identifying addressing systematic biases blind spots data, in AI systems derived that data, highlighted array potential problems fairness, accuracy, safety, reproducibility inferences conclusions. Work bias incompleteness health data sets includes studies find poor representation minority groups, seniors, women. See, example, https://www.eurekalert.org/pub_releases/2016-10/uoms-nsr100716.php, or https://datasociety.net/output/fairness-in-precision-medicine/?utm_sourc...). recent Wall Street Journal article https://www.wsj.com/articles/a-crucial-step-for-avoiding-ai-disasters-11...) noted computational tools developed a diverse team help avoid bias algorithms. Beyond problems biases other gaps data, research using health data humans requires special care protect sources the data see https://www.ncbi.nlm.nih.gov/pubmed?term=Barocas%2C%20Solon%5BAuthor%5D ). All Us Research Program https://allofus.nih.gov/) aims develop unbiased, representative health data resource, there many health data sets already use being constructed. Tools developed using biased incomplete data sets contribute erroneous analyses. Statistical fallacies representational errors unrelated the research question hand introduce systematic errors. core questions understanding mitigating and problems health data research are: can done, computationally and/or statistically, reduce mitigate gaps errors data sets used health research?" and, can improve tools used discovery, understanding, visualization health data sets their analyses?" Whether problem due incomplete health data inadequate tools, approaches needed strengthen reproducibility applicability data-centered research the etiology, epidemiology treatment health conditions. Research Objectives NLM invites research grant applications propose state the art methods approaches address problems large health data sets tools used analyze them, whether data drawn electronic health records public health data sets, biomedical imaging, omics repositories other biomedical social/behavioral data sets. Areas interest include are limited 1) developing testing computational statistical approaches applied large and/or merged health data sets holding human non-human data, a focus understanding characterizing gaps, errors, biases, other limitations the data inferences based the data; 2) exploring approaches correcting biases compensating missing data, including introduction debiasing techniques policies the of synthetic data; 3) testing new statistical algorithms other computational approaches strengthen research designs use specific types biomedical social/behavioral data; 4) generating metadata adequately characterizes data, including provenance, intended use, processes which was collected verified; 5) improving approaches integrating, mining, analyzing health data preserve confidentiality, accuracy, completeness overall security the data. Applicants should address ethical issues might arise their proposed approach. Application Submission Information Applications response this Notice must submitted through NLM’s funding opportunity announcement, PAR-18-896: NLM Research Grants Biomedical Informatics Data Science R01 Clinical Trial Optional). instructions PAR-18-896 must followed. Submissions should indicate they in response NOT-LM-19-003 Field 4.b the SF 424 R&R form. Program Directors/Principal Investigators PDs/PIs) planning submit applications this topic strongly encouraged contact scientific contact listed this Notice advice the appropriateness a potential application alignment NLM’s program priorities. Inquiries Please direct inquiries to: Alan Vanbiervliet, PhDNational Library Medicine/Extramural ProgramsTelephone: 301-594-4882Email: alan.vanbiervliet@nih.gov data science, computational, informatics, artificial intelligence, deep learning
Notice of Participation of the Office of Research Infrastructure Programs in PA-14-157 Early Stage Development of Technologies in Biomedical Computing NOT-OD-15-157 ORIP Sep 23 2015 N/A Notice Participation the Office Research Infrastructure Programs PA-14-157 Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R41/R42)" Notice Number: NOT-OD-15-157 Key Dates Release Date: September 23, 2015 Related Announcements PA-14-157     Issued Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Purpose purpose this Notice to inform potential applicants the Office Research Infrastructure Programs ORIP) participating, effective immediately, PA-14-157 quot;Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R41/R42)". following sections PA-14-157 been updated reflect ORIP participation this Funding Opportunity Announcement FOA.) Part 1.  Overview Information  Components Participating Organizations National Institute General Medical Sciences NIGMS) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Cancer Institute NCI) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Catalog Federal Domestic Assistance CFDA) Number(s) 93.859; 93.273; 93.361; 97.853; 93.286; 93.865; 93.846; 93.172; 93.113; 93.242; 93.879; 93.855; 93.856; 93.279; 93.393; 93.394; 93.395; 93.396; 93.399; 93.351 Part 2. Full Text Announcement Section VII. Agency Contacts Scientific/Research Contact(s) Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov Financial/Grants Management Contact(s) Artisha Y. Eatmon   National Center Advancing Translational Sciences NCATS) Office Research Infrastructure Programs ORIP) Telephone: 301-435-0845 Email: artisha.eatmon@nih.gov other changes made this FOA. Inquiries Please direct inquiries to: Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov data science, big data, informatics
Notice of Participation of the Office of Research Infrastructure Programs in PA-14-154 "Early Stage Development of Technologies in Biomedical Com NOT-OD-15-161 ORIP Sep 24 2015 N/A Notice Participation the Office Research Infrastructure Programs PA-14-154 Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R43/R44)" Notice Number: NOT-OD-15-161 Key Dates Release Date:   September 24, 2015 Related Announcements PA-14-154 Issued Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Purpose purpose this Notice to inform potential applicants the Office Research Infrastructure Programs ORIP) participating, effective immediately, PA-14-154 quot;Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R43/R44)". following sections PA-14-154 been updated reflect ORIP participation this FOA. Part 1.  Overview Information Components Participating Organizations National Institute General Medical Sciences NIGMS) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Cancer Institute NCI) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Catalog Federal Domestic Assistance CFDA) Number(s) 93.859; 93.273; 93.361; 97.853; 93.286; 93.865; 93.846; 93.172; 93.113; 93.242; 93.879; 93.855; 93.856; 93.279; 93.393; 93.394; 93.395; 93.396; 93.399; 93.351 Part 2. Full Text Announcement Section VII. Agency Contacts Scientific/Research Contact(s) Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov Financial/Grants Management Contact(s) Artisha Y. Eatmon   National Center Advancing Translational Sciences NCATS) Office Research Infrastructure Programs ORIP) Telephone: 301-435-0845 Email: artisha.eatmon@nih.gov other aspects this FOA remain same. Inquiries Please direct inquiries to: Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov data science, big data, informatics
Notice of Participation of NIGMS in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)" NOT-GM-16-112 NIGMS Aug 25 2016 N/A Notice Participation NIGMS RFA-MD-16-002 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-GM-16-112 Key Dates Release Date: August 25, 2016   Related Announcements RFA-MD-16-002 Issued National Institute General Medical Sciences NIGMS) Purpose purpose this Notice to add National Institute General Medical Sciences NIGMS) RFA-MD-16-002 nbsp;"NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections of RFA-MD-16-002 have updated reflect participation NIGMS this Funding Opportunity Announcement FOA). Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Heart, Lung, Blood Institute NHLBI) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Center Complementary Integrative Health NCCIH)  Office Research Infrastructure Programs ORIP) National Human Genome Research Institute NHGRI) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) National Library Medicine NLM) National Institute Aging NIA) National Eye Institute NEI) National Cancer Institute NCI) National Institute Drug Abuse NIDA) National Institute Alcohol Abuse Alcoholism NIAAA) National Center Advancing Translational Sciences NCATS) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Office Strategic Coordination Common Fund) Office Research Women’s Health ORWH) National Institute General Medical Sciences NIGMS) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307; 93.351; 93.846; 93.213; 93.113; 93.173; 93.837, 93.838, 93.839, 93.233, 93.840; 93.855; 93.856; 93.121; 93.172; 93.847;93.853; 93.879; 93.866; 93.310; 93.307; 93.867; 93.398; 93.279; 93.273; 93.350; 93.242; 93.865; 93.859 other aspects this Funding Opportunity Announcement remain same. Inquiries Please direct inquiries to: Susan K. Gregurick, Ph.D. National Institute General Medical Sciences NIGMS) Telephone: 301-594-5135 Email: Susan.gregurick@nih.gov data science, big data
Notice of Participation of Additional NIH Institutes and Centers in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomed NOT-HG-16-022 NHGRI Aug 08 2016 N/A Notice Participation Additional NIH Institutes Centers RFA-MD-16-002 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-HG-16-022 Key Dates Release Date:   August 8, 2016 Related Announcements RFA-MD-16-002     Issued National Human Genome Research Institute NHGRI) Purpose purpose this Notice to add additional NIH Institutes Centers ICs) RFA-MD-16-002 quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections RFA-MD-16-002 been updated reflect participation these additional ICs this Funding Opportunity Announcement FOA): Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Center Complementary Integrative Health NCCIH) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) National Human Genome Research Institute NHGRI) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) National Library Medicine NLM) National Institute Aging NIA) National Eye Institute NEI) National Cancer Institute NCI) National Institute Drug Abuse NIDA) National Institute Alcohol Abuse Alcoholism NIAAA) National Center Advancing Translational Sciences NCATS) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Office Strategic Coordination Common Fund) Office Research Women’s Health ORWH) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307; 93.351; 93.846; 93.213; 93.113; 93.173; 93.121; 93.172; 93.847;93.853; 93.879; 93.866; 93.310; 93.307; 93.867; 93.398; 93.279; 93.273; 93.350; 93.242; 93.865 other aspects this Funding Opportunity Announcement remain same. Inquiries Please direct inquiries to: Bettie J. Graham, Ph.D. Telephone: 301-496-7531 Email: bd2k_training@mail.nih.gov data science, big data

Pages

XLS